Aussie Scientists ID Gene That Blocks Main Hepatitis C Drugs In Many
This article was originally published in PharmAsia News
Executive Summary
Australian researchers say they have identified the gene responsible for the lack of the ability of half of Australians infected with hepatitis C to respond to conventional treatment. The Westmead Millenium Institute scientists said the interferon lambda gene has the ability to block the effectiveness of drugs used to treat the chronic infection of liver diseases. About 200,000 Australians have hepatitis C, half of whom fail to respond to the usual treatments. (Click here for more